Journal: Neurotrauma Reports
Article Title: A Small-Molecule TrkB/TrkC Ligand Promotes Neurogenesis and Behavioral Recovery Following Traumatic Brain Injury
doi: 10.1089/neur.2024.0117
Figure Lengend Snippet: Neurotrophic agents promote neural progenitor cell proliferation and survival in vitro . (A) Representative images of adult hippocampal progenitor (AHP) and embryonic neural stem (ENS) cells in culture media (CM) containing 0.1% FBS in the presence of the 0.7 nM BDNF or 1 µM LM22B-10. Cultures were maintained for 48 h prior to staining for BrdU; quantitation of BrdU+ cells. (B) AHP cells; LM22B-10 and BDNF increased BrdU+ cells, p < 0.0001 vs. CM, n = 20–40. (C) ENS cells; LM22B-10 increased BrdU+ cells, p < 0.0076 vs. CM, n = 10–20, while changes with BDNF were not significant. (D) P19 cell counts; LM22B-10 at 0.5, 1, and 2 µM similarly increased cell numbers, p = 0.0028, 0.0001, and 0.0002 vs. CM, n = 20. BDNF increased cell numbers, p = 0.0001 vs. CM, n = 20, to a greater extent than observed in 1 µM LM22B-10-exposed cells, p = 0.0001, n = 20 for the number of samples and using Student’s t test. In these studies, n represents sample numbers, the statistical significance of individual comparisons utilizes Student’s t test unless otherwise stated, and scale bars represent 10 µm. BrdU, 5′-bromo-2′-deoxyuridine.
Article Snippet: P19 mouse embryonic carcinoma cells, used for dose–response studies, were purchased from the American Type Culture Collection (ATCC) and grown in a minimal essential medium (Invitrogen), supplemented with 5% heat-inactivated fetal calf serum in 5% CO 2 at 37°C.
Techniques: In Vitro, Staining, Quantitation Assay